Key Points
Diabetics are at an increased risk of hypertension and its negative cardiovascular outcomes
Slow breathing reduces systolic blood pressure by 5.62 mmHg and diastolic blood pressure by 2.67 mmHg
Slow breathing is a simple way to reduce blood pressure and potentially improve cardiovascular outcomes
The Breathing Diabetic Summary
Hypertension is a significant risk factor for cardiovascular disease, which is the leading cause of death in the U.S. For instance, if systolic blood pressure rises from 115 mmHg to 135 mmHg, your risk of cardiovascular disease doubles.
People with diabetes are also much more likely to develop hypertension. Anywhere from 40 to 80% of diabetics have hypertension, a somewhat somber statistic. Moreover, I am writing this in April 2020 during the COVID-19 pandemic. Studies are revealing that hypertension is correlated with more severe complications.
All of this is to say that reducing blood pressure is more important than ever. There are several medications and lifestyle changes available; however, compliance with these approaches are often low. Therefore, alternative therapies are needed. One such treatment is slow breathing.
Slow Breathing and Hypertension
Slow breathing has consistently been shown to reduce blood pressure. In particular, a device called RESPeRATE (which is FDA approved), which slowly reduces breathing rate down to below ten breaths per minute, has been examined extensively. The American Heart Association has even given device-guided slow breathing a “class IIA” rating for reducing blood pressure.
This meta-analysis provides a concise yet comprehensive summary of studies that have examined slow breathing and hypertension. Their strict search criteria and thorough review of the available randomized controlled trials (RCTs) make this the most robust meta-analysis of slow breathing and blood pressure published to date.
Study Inclusion and Strict Search Criteria
The authors searched several public databases (e.g., Web of Science, MEDLINE) since their inception until mid-2015. They used a combination of search terms like “hypertension OR prehypertension” and “slow breathing OR device-guided breathing” to identify papers relevant to the meta-analysis.
In the identified papers, slow breathing was defined as anything below ten breaths per minute. The subjects had to perform slow breathing at least three times a week for at least 5 minutes each session. They included studies of people with both hypertension and prehypertension. The follow-up period had to be at least 4 weeks and changes in blood pressure had to be reported. They excluded studies of healthy subjects without baseline hypertension or prehypertension
Selecting Relevant Studies and Publication Bias
The authors started with 1,984 studies, but only 17 met their criteria for inclusion in the meta-analysis. Although meta-analyses are some of my favorites, there are caveats that we need to mention for this one.
Of the 17 studies selected, five were abstracts only. Additionally, only two had slow breathing without a device. The other fifteen were device-guided slow breathing using the RESPeRATE, and the maker of the device sponsored six of these. Thus, there was a high risk of publication bias with these studies.
Slow Breathing Significantly Reduces Blood Pressure
Despite these limitations, the collective results were impressive. The average decrease in systolic blood pressure (SBP) across all seventeen studies was 5.62 mmHg. The two non-device slow breathing studies had an even more significant drop of 7.69 mmHg. For diastolic blood pressure, the mean decrease was 2.67 mmHg for the device-guided slow breathing.
Longer Practice Leads to Better Results
They also examined how the intensity of the slow breathing practice affected results—the conclusion: the longer subjects practiced, the greater their reduction in blood pressure. For example, for slow breathing <100 min a week, the decrease in SBP was 3.01 mmHg, for 100-200 min, it was 6.44 mmHg, and for >200 min, it was 14.00 mmHg.
Reduced Blood Pressure Reduces Risk of Death
The significance of these findings is that modest reductions in blood pressure lower the chances of strokes, coronary events, heart failure, cardiovascular deaths, and total deaths. This is especially important for diabetics who are at higher risk of developing hypertension and heart disease.
Moreover, the improvements from slow breathing were similar to those seen with antihypertensive medications. Those medications have been shown to improve long-term outcomes in hypertensive and prehypertensive patients. Therefore, slow breathing could potentially provide similar positive results if practiced consistently over a long period.
Slow Breathing is Free and Has No Side Effects
Finally, slow breathing is free, easy to perform, and does not have any side effects. Moreover, the blood-pressure-lowering effects of slow breathing are far-reaching. For example, slow breathing helps with stress, anxiety, and depression, all of which will also help reduce blood pressure.
A Recap of the Main Points
In summary, slow breathing reduces systolic blood pressure by 5.62 mmHg and diastolic blood pressure by 2.67 mmHg. The more time you practice per week, the greater the blood pressure reductions. Slow breathing also lowers blood pressure by helping with anxiety, stress, and depression. And by lowering your blood pressure, you reduce the risk of many cardiovascular problems, like stroke or heart disease.
To begin, try breathing at six breaths per minute (4 sec inhale, 6 sec exhale) for five minutes a day and see how you feel.
Abstract
OBJECTIVES: Interest is increasing in nonpharmacological interventions to treat blood pressure in hypertensive and prehypertensive patients at low cardiac risk. This meta-analysis of randomized controlled trials assesses the impact of device-guided and non-device-guided (pranayama) slow breathing on blood pressure reduction in these patient populations.
METHODS: We searched PubMed, EMBASE, CINAHL, Cochrane CENTRAL, Cochrane Database of Systematic Reviews, Web of Science, BIOSIS (Biological Abstracts) Citation Index and Alt HealthWatch for studies meeting these inclusion criteria: randomized controlled trial or first phase of a randomized cross-over study; subjects with hypertension, prehypertension or on antihypertensive medication; intervention consisting of slow breathing at ≤10 breaths/minute for ≥5 min on ≥3 days/week; total intervention duration of ≥4 weeks; follow-up for ≥4 weeks; and a control group. Data were extracted by two authors independently, the Cochrane Risk of Bias Tool assessed bias risk, and data were pooled using the DerSimonian and Laird random effects model. Main outcomes included changes in systolic (SBP) and/or diastolic blood pressure (DBP), heart rate (HR), and/or decreased antihypertensive medication.
RESULTS: Of 103 citations eligible for full-text review, 17 studies were included in the meta-analysis. Overall, slow breathing decreased SBP by -5.62 mmHg [-7.86, -3.38] and DBP by -2.97 mmHg [-4.28, -1.66]. Heterogeneity was high for all analyses.
CONCLUSIONS: Slow breathing showed a modest reduction in blood pressure. It may be a reasonable first treatment for low-risk hypertensive and prehypertensive patients who are reluctant to start medication.
Journal Reference:
Chaddha A, Modaff D, Hooper-Lane C, Feldstein DA. Device and non-device-guided slow breathing to reduce blood pressure: A systematic review and meta-analysis. Complement Ther Med. 2019;45:179-184. doi: 10.1016/j.ctim.2019.03.005.
